The Diagnostic Accuracy of Methylation Markers in Urine for The Detection of Bladder Cancer: A Systematic Review

References

• International Agency for Research on Cancer . Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012 . 14 November 2016 . http://globocan.iarc.fr/Pages/fact_sheets_population.aspx .
   Google Scholar
• Van Rhijn BW , BurgerM , LotanYet al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy . Eur. Urol.56 ( 3 ), 430 – 442 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Babjuk M , BohleA , BurgerMet al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016 . Eur. Urol.71 ( 3 ), 447 – 461 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Svatek RS , HollenbeckBK , HolmangSet al. The economics of bladder cancer: costs and considerations of caring for this disease . Eur. Urol.66 ( 2 ), 253 – 262 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Lotan Y , RoehrbornCG . Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses . Urology61 ( 1 ), 109 – 118 ; discussion 118 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Jones PA , BaylinSB . The fundamental role of epigenetic events in cancer . Nat. Rev. Genet.3 ( 6 ), 415 – 428 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Ralla B , StephanC , MellerS , DietrichD , KristiansenG , JungK . Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies . Crit. Rev. Clin. Lab. Sci.51 ( 4 ), 200 – 231 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Moher D , LiberatiA , TetzlaffJ , AltmanDG ; The PRISMA Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement . PLoS Med.6 ( 7 ), e1000097 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Deeks JJ , BossuytPM , GatsonisC ( Eds ). Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 0.9 . Cochrane Collaboration ( 2013 ).
   Google Scholar
• Whiting PF , RutjesAW , WestwoodMEet al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies . Ann. Intern. Med.155 ( 8 ), 529 – 536 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Aleman A , AdrienL , Lopez-SerraLet al. Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays . Br. J. Cancer98 ( 2 ), 466 – 473 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Andersson E , DahmckeCM , StevenK , LarsenLK , GuldbergP . Filtration device for on-site collection, storage and shipment of cells from urine and its application to DNA-based detection of bladder cancer . PLoS ONE10 ( 7 ), e0131889 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Cabello MJ , GrauL , FrancoNet al. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer . J. Mol. Diagn.3 ( 1 ), 29 – 40 ( 2011 ).
   Google Scholar
• Cebrian V , AlvarezM , AlemanAet al. Discovery of myopodin methylation in bladder cancer . J. Pathol.216 ( 1 ), 111 – 119 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chan MW , ChanLW , TangNLet al. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients . Int. J. Cancer104 ( 5 ), 611 – 616 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Chan MW , ChanLW , TangNLet al. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients . Clin. Cancer Res.8 ( 2 ), 464 – 470 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Chihara Y , KanaiY , FujimotoHet al. Diagnostic markers of urothelial cancer based on DNA methylation analysis . BMC Cancer13 , 275 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chung W , BondarukJ , JelinekJet al. Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments . Cancer Epidemiol. Biomarkers Prev.20 ( 7 ), 1483 – 1491 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Costa VL , HenriqueR , DanielsenSAet al. Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samples . Clin. Cancer Res.16 ( 23 ), 5842 – 5851 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Costa VL , HenriqueR , DanielsenSAet al. TCF21 and PCDH17 methylation: an innovative panel of biomarkers for a simultaneous detection of urological cancers . Epigenetics6 ( 9 ), 1120 – 1130 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Dahmcke CM , StevenKE , LarsenLKet al. A prospective blinded evaluation of urine-DNA testing for detection of urothelial bladder carcinoma in patients with gross hematuria . Eur. Urol.70 ( 6 ), 916 – 919 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Dulaimi E , UzzoRG , GreenbergRE , Al-SaleemT , CairnsP . Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel . Clin. Cancer Res.10 ( 6 ), 1887 – 1893 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Fantony JJ , AbernMR , GopalakrishnaAet al. Multi-institutional external validation of urinary TWIST1 and NID2 methylation as a diagnostic test for bladder cancer . Urol. Oncol.33 ( 9 ), 387 ; e381 – 386 ( 2015 ).
   Web of Science ®Google Scholar
• Fernandez CA , MillhollandJM , ZwarthoffEC , FeldmanAS , KarnesRJ , ShuberAP . A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patients . Res. Rep. Urol.4 , 17 – 26 ( 2012 ).
   PubMedGoogle Scholar
• Friedrich MG , WeisenbergerDJ , ChengJCet al. Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients . Clin. Cancer Res.10 ( 22 ), 7457 – 7465 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Garcia-Baquero R , PuertaP , BeltranMet al. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study . J. Urol.190 ( 2 ), 723 – 730 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hayashi M , BernertH , KagoharaLTet al. Epigenetic inactivation of VGF associated with urothelial cell carcinoma and its potential as a non-invasive biomarker using urine . Oncotarget5 ( 10 ), 3350 – 3361 ( 2014 ).
   PubMedGoogle Scholar
• Hoque MO , BegumS , TopalogluOet al. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection . J. Natl Cancer Inst.98 ( 14 ), 996 – 1004 ( 2006 ).
   PubMedGoogle Scholar
• Kandimalla R , MasiusR , BeukersWet al. A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine . Clin. Cancer Res.19 ( 17 ), 4760 – 4769 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lee J , WysockiPT , TopalogluOet al. Epigenetic silencing of S100A2 in bladder and head and neck cancers . Oncoscience2 ( 4 ), 410 – 418 ( 2015 ).
   PubMedGoogle Scholar
• Lin HH , KeHL , HuangSP , WuWJ , ChenYK , ChangLL . Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine . Urol. Oncol.28 ( 6 ), 597 – 602 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Maldonado L , BraitM , MichailidiCet al. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine . Oncotarget5 ( 14 ), 5218 – 5233 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Pietrusinski M , KepczynskiL , JedrzejczykAet al. Detection of bladder cancer in urine sediments by a hypermethylation panel of selected tumor suppressor genes . Cancer Biomark.18 ( 1 ), 47 – 59 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Reinert T , BorreM , ChristiansenA , HermannGG , OrntoftTF , DyrskjotL . Diagnosis of bladder cancer recurrence based on urinary levels of EOMES, HOXA9, POU4F2, TWIST1, VIM, and ZNF154 hypermethylation . PLoS ONE7 ( 10 ), e46297 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Reinert T , ModinC , CastanoFMet al. Comprehensive genome methylation analysis in bladder cancer: identification and validation of novel methylated genes and application of these as urinary tumor markers . Clin. Cancer Res.17 ( 17 ), 5582 – 5592 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Renard I , JoniauS , Van CleynenbreugelBet al. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples . Eur. Urol.58 ( 1 ), 96 – 104 ( 2010 ).
   PubMedGoogle Scholar
• Roperch JP , GrandchampB , DesgrandchampsFet al. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer . BMC Cancer16 , 704 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Roupret M , HupertanV , YatesDRet al. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis . BJU Int.101 ( 11 ), 1448 – 1453 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Scher MB , ElbaumMB , MogilevkinYet al. Detecting DNA methylation of the BCL2, CDKN2A and NID2 genes in urine using a nested methylation specific polymerase chain reaction assay to predict bladder cancer . J. Urol.188 ( 6 ), 2101 – 2107 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Serizawa RR , RalfkiaerU , StevenKet al. Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diagnostic value of FGFR3 mutations and hypermethylation events . Int. J. Cancer129 ( 1 ), 78 – 87 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Urakami S , ShiinaH , EnokidaHet al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection . Clin. Cancer Res.12 ( 7 Pt 1 ), 2109 – 2116 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Van Kessel KE , BeukersW , LurkinIet al. Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy . J. Urol.197 ( 3, Pt 1 ), 590 – 595 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Van Kessel KE , Van NesteL , LurkinI , ZwarthoffEC , Van CriekingeW . Evaluation of an epigenetic profile for the detection of bladder cancer in patients with hematuria . J. Urol.195 ( 3 ), 601 – 607 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Vinci S , GiannariniG , SelliCet al. Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: a prospective, two-center validation study . Urol. Oncol.29 ( 2 ), 150 – 156 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang K , TianY , XuH . Improved noninvasive bladder cancer diagnosis using urine sediments and novel DNA methylation biomarker panels . Clin. Lab.62 ( 3 ), 327 – 336 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , YuY , YeRet al. An epigenetic biomarker combination of PCDH17 and POU4F2 detects bladder cancer accurately by methylation analyses of urine sediment DNA in Han Chinese . Oncotarget7 ( 3 ), 2754 – 2764 ( 2016 ).
   PubMedGoogle Scholar
• Yates DR , RehmanI , MeuthM , CrossSS , HamdyFC , CattoJW . Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls . Oncogene25 ( 13 ), 1984 – 1988 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Yegin Z , GunesS , BuyukalpelliR . Hypermethylation of TWIST1 and NID2 in tumor tissues and voided urine in urinary bladder cancer patients . DNA Cell Biol.32 ( 7 ), 386 – 392 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yeh CM , ChenPC , HsiehHYet al. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma . Oncotarget6 ( 30 ), 29555 – 29572 ( 2015 ).
   PubMedGoogle Scholar
• Yu J , ZhuT , WangZet al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer . Clin. Cancer Res.13 ( 24 ), 7296 – 7304 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Zhao Y , GuoS , SunJet al. Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population . PLoS ONE7 ( 4 ), e35175 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zuiverloon TC , BeukersW , Van Der KeurKAet al. A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine . BJU Int.109 ( 6 ), 941 – 948 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Beukers W , Van Der KeurKA , KandimallaRet al. FGFR3, TERT and OTX1 as a urinary biomarker combination for surveillance of patients with bladder cancer in a large prospective multicenter study . J. Urol.197 ( 6 ), 1410 – 1418 ( 2017 ).
   PubMed Web of Science ®Google Scholar
• Marsit CJ , HousemanEA , SchnedAR , KaragasMR , KelseyKT . Promoter hypermethylation is associated with current smoking, age, gender and survival in bladder cancer . Carcinogenesis28 ( 8 ), 1745 – 1751 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Montori VM , WyerP , NewmanTB , KeitzS , GuyattG ; Evidence-Based Medicine Teaching Tips Working Group . Tips for learners of evidence-based medicine: 5. The effect of spectrum of disease on the performance of diagnostic tests . CMAJ173 ( 4 ), 385 – 390 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Lijmer JG , MolBW , HeisterkampSet al. Empirical evidence of design-related bias in studies of diagnostic tests . JAMA282 ( 11 ), 1061 – 1066 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Pepe MS , EtzioniR , FengZet al. Phases of biomarker development for early detection of cancer . J. Natl Cancer Inst.93 ( 14 ), 1054 – 1061 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Van Rhijn BW , Van Der PoelHG , Van Der KwastTH . Urine markers for bladder cancer surveillance: a systematic review . Eur. Urol.47 ( 6 ), 736 – 748 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Chen H , YuY , RongS , WangH . Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis . Biomarkers19 ( 3 ), 189 – 197 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Macaskill PGC , DeeksJJ , HarbordRM , TakwoingiY . Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0 . The Cochrane Collaboration ( 2010 ). http://srdta.cochrane.org/ .
   Google Scholar